liposomal glutathione bioavailability study randomized liposomal glutathione bioavailability study randomized

Claire Bennett, ADC Development Manager (UK) "We required customized enzyme-cleavable linkers for preclinical ADC studies

Polyethylene glycol-like brush polymer conjugate of a protein drug does not induce an antipolymer immune response and has enhanced pharmacokinetics than its polyethylene glycol counterpart

In contrast, we observed an increase basal coronary blood flow, which is in accordance with observations in humans with diabetes and CKD [35, 43, 50], but also patients with HFpEF in general [1] and is likely to be explained by the hearts heightened metabolic and oxygen demands imposed by elevated cardiac after- and/or preload [2]

Together, they offer a realistic view of what to expect